Floatz logo

PHENYTOIN

Cognitive Measures

University of IowaSmall moleculePhase 4 / ApprovedDormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

150 Active assets in the Cognitive Measures cohort.

Asset / SponsorPhaseRating
Ginkgo Biloba Extract
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4BBB
Rivastigmine
Singapore General Hospital
Phase 4BBB
Nicotine
University of Southern California
Phase 2BBB
Oxybutynin
University of Alberta
Phase 4BBB
Seroquel®
Emory University
Phase 4BB

View all 50 →

Same molecule, other indications

PHENYTOIN is also rated in:

epilepsyDormant
BB
Indicative ·
66 / 100
View asset →
traumatic brain injuryDormant
B
Indicative ·
63 / 100
View asset →
epilepsy with generalized tonic-clonic seizuresDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →